"Isolate Id","Study","Species","Organism Group","Country","State","Gender","Age Group","Speciality","Source","In / Out Patient","Year","Phenotype","MIC","breakpoint","Drug"
"1625495","TEST","Acinetobacter ursingii","Non-Enterobacteriaceae","Argentina",NA,"Female","65 to 84 Years","None Given","Bodily Fluids: Tissue","None Given","2017",NA,"<=0.5","Susceptible","Amikacin"
"1625495","TEST","Acinetobacter ursingii","Non-Enterobacteriaceae","Argentina",NA,"Female","65 to 84 Years","None Given","Bodily Fluids: Tissue","None Given","2017",NA,"4","Susceptible","Cefepime"
"1625495","TEST","Acinetobacter ursingii","Non-Enterobacteriaceae","Argentina",NA,"Female","65 to 84 Years","None Given","Bodily Fluids: Tissue","None Given","2017",NA,"16","Intermediate","Ceftazidime"
"1625495","TEST","Acinetobacter ursingii","Non-Enterobacteriaceae","Argentina",NA,"Female","65 to 84 Years","None Given","Bodily Fluids: Tissue","None Given","2017",NA,"8","Susceptible","Ceftriaxone"
"1625495","TEST","Acinetobacter ursingii","Non-Enterobacteriaceae","Argentina",NA,"Female","65 to 84 Years","None Given","Bodily Fluids: Tissue","None Given","2017",NA,"0.12","Susceptible","Levofloxacin"
"1625495","TEST","Acinetobacter ursingii","Non-Enterobacteriaceae","Argentina",NA,"Female","65 to 84 Years","None Given","Bodily Fluids: Tissue","None Given","2017",NA,"0.5","Susceptible","Meropenem"
"1625495","TEST","Acinetobacter ursingii","Non-Enterobacteriaceae","Argentina",NA,"Female","65 to 84 Years","None Given","Bodily Fluids: Tissue","None Given","2017",NA,"<=0.5","Susceptible","Minocycline"
"1625495","TEST","Acinetobacter ursingii","Non-Enterobacteriaceae","Argentina",NA,"Female","65 to 84 Years","None Given","Bodily Fluids: Tissue","None Given","2017",NA,"4","Susceptible","Piperacillin tazobactam"
